Study of pro-and anti-inflammatory cytokine profile in the patients with parthenium dermatitis

Contact Dermatitis

Volumn 63, Issue 4, 2010, Pages 203-208

  Akhtar, Nasim ^a   Verma, Kaushal K ^a   Sharma, Alpana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

anti inflammatory; cytokines; delayed type hypersensitivity; IL 10; IL 17; IL 4; IL 6; IL 8; parthenium dermatitis; Parthenium hysterophorus; pro inflammatory; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; PAPULE; PARTHENIUM HYSTEROPHORUS; SENSITIVITY AND SPECIFICITY; SKIN ALLERGY; WEED;

ADULT; AGED; ANTIGENS, PLANT; ASTERACEAE; DERMATITIS, ALLERGIC CONTACT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; MIDDLE AGED; PATCH TESTS; PLANT EXTRACTS; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956512869     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/j.1600-0536.2009.01693.x     Document Type: Article

References (47)

1. Verma K K, Bansal A, Sethuraman G. Parthenium dermatitis treated with azathioprine weekly pulse doses. Indian J Dermatol Venereol Leprol 2006: 72: 24 27.
2. Towers G H, Mitchell J C. The current status of the weed Parthenium hysterophorus L. as a cause of allergic contact dermatitis. Contact Dermatitis 1983: 9: 465 469.
3. Navie S C, McFadyen R E, Panetta F D, Adkins S W. The biology of Australian weeds 27. Parthenium hysterophorus L. Plant Prot Quat 1966: 11: 76 88.
4. Sharma V K, Sethuraman G. Parthenium dermatitis. Dermatitis 2007: 18: 183 190.
5. Agarwal K K, D'Souza M. Airborne contact dermatitis induced by parthenium: a study of 50 cases in South India. Clin Exp Dermatol 2009: 34: e4 e6.
6. Verma K K, Mahesh R, Srivastava P, Ramam M, Mukhopadhyaya A K. Azathioprine versus betamethasone for the treatment of parthenium dermatitis: a randomized controlled study. Indian J Dermatol Venereol Leprol 2008: 74: 453 457.
7. Ríos J L, Bas E, Recio M C. Effects of natural products on contact dermatitis. Curr Med Chem-Anti-Inflamm & Anti-Allergy Agents 2005: 4: 65 80.
8. Ross R, Reske-Kunz A B. The role of NO in contact hypersensitivity. Int Immunopharmacol 2001: 1: 1469 1478.
9. Kimber I, Basketter D A, Gerberick G F, Dearman R J. Allergic contact dermatitis. Int Immunopharmacol 2002: 2: 201 211.
10. Kimber I, Dearman R J. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 2002: 46: 1 5.
11. Kasai T, Inada K, Takakuwa T et al. Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1997: 98: 34 42.
12. Opal S M, DePalo V A. Anti-inflammatory cytokines. Chest 2000: 117: 1162 1172.
13. Sharma A, Rajappa M, Saxena A, Sharma M. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int J Gynecol Cancer 2007: 17: 879 885.
14. Kelso A. Th1 and Th2 subsets: paradigms lost?. Immunol Today 1995: 16: 374 379.
15. Abbas A K, Lichtman A H. Immunity to microbes. In: Cellular and Molecular Immunology, 5th edition, Abbas A K, Lichtman A H (eds), chapter 15: Philadelphia, USA, Saunders, 2003: 345 366.
16. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006: 116: 1218 1222.
17. Verma K K, Manchanda Y, Dwivedi S N. Failure of titer of contact hypersensitivity to correlate with clinical severity and therapeutic response in contact dermatitis caused by parthenium. Indian J Dermatol Venereol Leprol 2004: 70: 210 213.
18. Pasricha J S, Singh S N. Evaluation of the antigen-impregnated discs for patch tests. Indian J Dermatol Venereol 1982: 48: 327 329.
19. Xing Z, Gauldie J, Cox G et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998: 101: 311 320.
20. Chiu B C, Freeman C M, Stolberg V R et al. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am J Respir Cell Mol Biol 2003: 29: 106 116.
21. Docke W D, Randow F, Syrbe U et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 1997: 3: 678 681.
22. Zedler S, Bone R C, Baue A E, Henkel von Donnersmarck G, Faist E. T-cell reactivity and its predictive role in immunosuppression after burns. Crit Care Med 1999: 27: 66 72.
23. Girolamo N D, Visvanathan K, Lloyd A, Wakefield D. Expression of TNF-a by human plasma cells in chronic inflammation. J Leukoc Biol 1997: 61: 667 678. (Pubitemid 27276058)
24. Ryan G B, Majno G. Acute inflammation. Am J Pathol 1977: 86: 185 274.
25. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th-1 cell-mediated murine colitis. J Immunol 2000: 164: 4878 4882.
26. Westphal G A, Schnuch A, Moessner R et al. Cytokine gene polymorphisms in allergic contact dermatitis. Contact Dermatitis 2003: 48: 93 98.
27. Skov L, Beurskens F J, Zachariae C O C et al. IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis. J Immunol 2008: 181: 669 679.
28. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 1994: 55: 97 179.
29. Schall T J, Bacon K B. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994: 6: 865 873.
30. Sticherling M, Sautier W, Schroder J M, Christophers E. Interleukin-8 plays its role at local level in psoriasis vulgaris. Acta Derm Venereol 1999: 79: 4 8.
31. Anttila H S I, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 1992: 98: 96 101.
32. Duan H, Koga T, Kohda F, Hara H, Urabe K, Furue M. Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci 2001: 26: 119 124.
33. Kilciler G, Musabak U, Bagci S et al. Do the changes in the serum levels of IL-2, IL-4, TNFα, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis?. Clin Dev Immunol 2008: 15: 481 560.
34. Almakhzangy I, Gaballa A. Serum level of IL-17, IL-22, IFN-γ in patients with psoriasis. Egyptian Dermatol Online J 2009.
35. H17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 2009: 123: 486 492.
36. Watkins S A, Maibach H I. The hardening phenomenon in irritant contact dermatitis: an interpretative update. Contact Dermatitis 2009: 60: 123 130.
37. Ebnet K, Vestweber D. Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem Cell Biol 1999: 112: 1 23.
38. Lisinski T J, Furie M B. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1ß or TNF-α. J Leukoc Biol 2002: 72: 503 511.
39. Woods J M, Katschke K J, Volin M V et al. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. J Immunol 2001: 166: 1214 1222.
40. Yagi J, Arimura Y, Takatori H, Nakajima H, Iwamoto I, Uchiyama T. Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+T cells Int Immunol 2006: 18: 1681 1690.
41. H2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999: 103: 1103 1111.
42. Clarke C J, Hales A, Hunt A, Foxwell B M. IL-10 mediated suppression of TNF-a production is independent of its ability to inhibit NF-kB activity. Eur J Immunol 1998: 28: 1719 1726.
43. Grimbaldeston M A, Nakae S, Kalesnikoff J, Tsai M, Galli S J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007: 8: 1095 1104.
44. H1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007: 7: 425 428.
45. Fuss I J, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol 2002: 168: 900 908.
46. Ohmen J D, Hanifin J M, Nickoloff B J et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995: 154: 1956 1963.
47. Homey B, Steinhoff M, Ruzicka T, Leung D Y M. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006: 118: 178 189. (Pubitemid 43946487)